Profiel
Christina Cameron is currently Director-Investor Relations at Medicago, Inc., Vice President-Investor Relations at Antibe Therapeutics, Inc., and Investor Relations & Media Contact at Medicenna Therapeutics Corp.
from 2019 to present.
Formerly, Ms. Cameron was an Independent Director at Zero Candida Technologies, Inc. from 2024 to 2026.
Education includes an undergraduate degree from Wilfrid Laurier University.
Actieve functies van Christina Cameron
| Bedrijven | Functie | Begin |
|---|---|---|
| ANTIBE THERAPEUTICS INC. | Investor Relations Contact | - |
| MEDICENNA THERAPEUTICS CORP. | Investor Relations Contact | 01-02-2019 |
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Investor Relations Contact | - |
Eerdere bekende functies van Christina Cameron
| Bedrijven | Functie | Einde |
|---|
Opleiding van Christina Cameron
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Wilfrid Laurier University
Wilfrid Laurier University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Antibe Therapeutics, Inc.
Antibe Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops pain and inflammation drugs | Health Technology |
Medicenna Therapeutics Corp.
Medicenna Therapeutics Corp. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
















